Topic: Cardiology

Irish-German cardiac imaging startup OneProjects today announced $8 million in Series A2 funding and two […]

The Mountain View, CA-based company will now be able to offer a full suite of cardiac monitoring services.

Boston Scientific (NYSE:BSX) announced today that it agreed to acquire Baylis Medical for an upfront payment of $1.75 […]

Annoviant announced today that it received a $1.85 million NIH grant to help further the development […]

The AI solution automatically analyses cardiac CT scans and produces reports within 15 minutes.

Boston Scientific (NYSE:BSX) will invest €30 million (about $34 million) in its Cork, Ireland facility, […]

GE Healthcare (NYSE:GE) today announced that it has launched its MyoSpect cardiac-dedicated nuclear scanner. Chicago-based GE […]

The new watch is launching in France, Germany and the UK.

This comes just a month after news broke Nanox was set to acquire Zebra Medical Vision.

MedAlliance announced today that it completed patient enrollment for a trial of its Selution SLR […]

Abbott (NYSE:ABT) today announced U.S. FDA approval of its Portico with FlexNav TAVR system. The […]

With the results of a recent trial, Abbott is seeking an expanded indication from the FDA for its CardioMEMS device, intended to prevent hospitalizations in patients with heart failure. It’s also hoping to win over national coverage from CMS.

TransMedics (NSDQ:TMDX) announced today that it received FDA premarket approval for its OCS Heart system. Andover, […]

Abbott (NYSE:ABT) touted its Amplatzer Amulet device as superior according to results from a head-to-head trial […]

Stereotaxis this week announced it has forged a broad collaboration with Shanghai Microport EP Medtech […]

Medtronic (NYSE:MDT) today touted data demonstrating reductions in reinterventions and complications with its Micra pacemaker. Fridley, […]

Shockwave Medical, a medtech company based in California, has developed a technique called intravascular lithotripsy, […]

iRhythm is changing the game in a heart rhythm monitoring space that has been dominated […]

The device predicts cardiac arrests using four primary vital signs.

The EMPOWER trial will evaluate Cardiac Dimensions’ Carillon Mitral Contour System and look at about 300 patients at 75 sites.

Medtronic’s Micra pacemakers are one-tenth the size of what was previously out there. How the […]

Abiomed (NSDQ:ABMD) today announced that the FDA has granted breakthrough device designation for its Impella ECP […]

Abbott today announced that it has received FDA approval for its Amplatzer Amulet device to […]

Ultromics’ EchoGo Core and EchoGo Pro platforms quickly deliver highly accurate assessments of heart function that support the diagnosis of coronary artery disease.

The Irvine, CA-based company said its ALIGN-AR pivotal trial will evaluate its Trilogy Heart Valve system.

Dive Brief: Abbott Laboratories received FDA approval for its Amplatzer Amulet left atrial appendage occluder device used […]

The Xplore2/Pivotal study is for patients requiring right ventricular outflow tract (RVOT) reconstruction to correct certain congenital heart defects.

Abiomed  (NASDAQ: ABMD) posted first-quarter results that beat the consensus forecast on Wall Street, with the […]

The proceeds will enable the company to complete development and perform its first clinical trial.

Abbott has received clearance from the FDA for its imaging software that uses artificial intelligence to provide doctors a better view of blood flow and blockages in heart vessels.

Tenaya Therapeutics announced that it priced an underwritten, upsized initial public offering of common stock worth […]

Abbott (NYSE:ABT) announced that it launched the Jot Dx — its latest insertable cardiac monitor (ICM) […]

Medtronic (NYSE:MDT) announced today that the FDA cleared two of its AccuRhythm AI algorithms for use […]

Collaboration Aims to Explore Benefits of Remote Monitoring of Patients Pre- and Post-Ablation

Medtronic today announced that it has launched its Prevail drug-coated balloon catheter in Europe. Dublin-based […]

Studies suggest Elucid’s AI software helps to objectively quantify key drivers of stroke and heart attack from computed tomography angiography (CTA).

They will highlight the application of digital cardiac rehabilitation in cardio-oncology.

French artificial heart maker Carmat recently reported the first U.S. implantation of its bioprosthetic artificial […]

Santa Clara, CA-based Ancora Heart is developing the AccuCinch System, a device-therapy designed to improve the structure and function of the heart and help bring relief to HF patients who remain symptomatic despite current guideline-directed medical care.